Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curt D Furberg

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Atherosclerosis|October 7, 2009
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health StudyNancy Swords Jenny, Cam Solomon, Mary Cushman, et al.
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Experience collecting interim data on mortality: an example from the RALES studyJanet Wittes, Jolie Palensky, Debra Asner, et al.
Circulation|December 10, 2008
Prevalence, prognosis, and implications of isolated minor nonspecific ST-segment and T-wave abnormalities in older adults: Cardiovascular Health StudyAnita Kumar, Ronald J Prineas, Alice M Arnold, et al.
Journal of the American College of Cardiology|April 12, 2008
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology FoundationJohn D Brunzell, Michael Davidson, Curt D Furberg, et al.
Trials|January 6, 2011
A Polypill for primary prevention of cardiovascular disease: a feasibility study of the World Health OrganizationElsayed Z Soliman, Shanthi Mendis, Wasantha P Dissanayake, et al.
Circulation. Cardiovascular Quality and Outcomes|April 14, 2011
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular riskAllan D Sniderman, Ken Williams, John H Contois, et al.
Diabetes Care|April 1, 2008
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology FoundationJohn D Brunzell, Michael Davidson, Curt D Furberg, et al.
Circulation|March 27, 2002
Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factorsFrank M Sacks, Andrew M Tonkin, Timothy Craven, et al.
Stroke|October 5, 2002
Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health StudyW T Longstreth, Corinne Dulberg, Teri A Manolio, et al.
Annals of Internal Medicine|September 3, 2002
Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack TrialBarry R Davis, Jeffrey A Cutler, Curt D Furberg, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Atherosclerosis|October 7, 2009
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health StudyNancy Swords Jenny, Cam Solomon, Mary Cushman, et al.
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Experience collecting interim data on mortality: an example from the RALES studyJanet Wittes, Jolie Palensky, Debra Asner, et al.
Circulation|December 10, 2008
Prevalence, prognosis, and implications of isolated minor nonspecific ST-segment and T-wave abnormalities in older adults: Cardiovascular Health StudyAnita Kumar, Ronald J Prineas, Alice M Arnold, et al.
Journal of the American College of Cardiology|April 12, 2008
Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology FoundationJohn D Brunzell, Michael Davidson, Curt D Furberg, et al.
Trials|January 6, 2011
A Polypill for primary prevention of cardiovascular disease: a feasibility study of the World Health OrganizationElsayed Z Soliman, Shanthi Mendis, Wasantha P Dissanayake, et al.
Circulation. Cardiovascular Quality and Outcomes|April 14, 2011
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular riskAllan D Sniderman, Ken Williams, John H Contois, et al.
Diabetes Care|April 1, 2008
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology FoundationJohn D Brunzell, Michael Davidson, Curt D Furberg, et al.
Circulation|March 27, 2002
Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factorsFrank M Sacks, Andrew M Tonkin, Timothy Craven, et al.
Stroke|October 5, 2002
Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health StudyW T Longstreth, Corinne Dulberg, Teri A Manolio, et al.
Annals of Internal Medicine|September 3, 2002
Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack TrialBarry R Davis, Jeffrey A Cutler, Curt D Furberg, et al.
Pageof 17